Interleukin-2

From Wikipedia, the free encyclopedia
Jump to: navigation, search

Interleukin-2 is a form of Interleukin. It is important in medicine because it is an effective treatment for metastatic renal cell carcinoma and Metastatic melanoma. It can produce up to a 16% response rate in patients with Metastatic melanoma.[1] and a slightly lower 15% response rate in metastatic renal cell carcinoma.[2]

References[change | edit source]